Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants
The ongoing pandemic of COVID-19, caused by SARS-CoV-2, has severely impacted the global public health and socio-economic stability, calling for effective vaccines and therapeutics. In this study, we continued our efforts to develop more efficient SARS-CoV-2 fusion inhibitors and achieved significan...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2021-01-01
|
| Schriftenreihe: | Emerging Microbes and Infections |
| Schlagworte: | |
| Online-Zugang: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1937329 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
